Resveratrol inhibits nonalcoholic fatty liver disease in rats

被引：0
|
作者：
Luis Bujanda
Elizabeth Hijona
Mikel Larzabal
Marta Beraza
Pablo Aldazabal
Nerea García-Urkia
Cristina Sarasqueta
Angel Cosme
Belen Irastorza
Alberto González
Juan I Arenas
机构：
[1] Donostia Hospital,Department of Gastroenterology, University of Country Basque
[2] Centro de Investigación Biomédica en Enfermedades Hepáticas y Digestivas (CIBERehd),Department of Pathology
[3] Donostia Hospital,Department of Experimental Surgery
[4] Donostia Hospital,Department of Epidemiology
[5] Donostia Hospital,Department of Pharmacology
[6] Donostia Hospital,Department of Microbiology
[7] Donostia Hospital,undefined
来源：
BMC Gastroenterology | / 8卷
关键词：
Resveratrol; Hepatic Steatosis; Bacterial Translocation; Fatty Infiltration; Nonalcoholic Fatty Liver Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of aerobic exercise and resveratrol on adipocytokines in rats with nonalcoholic fatty liver disease
    Wang, G. H.
    Ruan, L.
    Wu, R. P.
    Jin, Z.
    SCIENCE & SPORTS, 2023, 38 (01) : 57 - 67
  • [2] Nonalcoholic Fatty Liver Disease
    Worm, N.
    Stein, J.
    Strohle, A.
    DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (02): : 85 - 94
  • [3] Nonalcoholic Fatty Liver Disease
    Law, Kathryn
    Brunt, Elizabeth M.
    CLINICS IN LIVER DISEASE, 2010, 14 (04) : 591 - +
  • [4] The Intervention of Nonalcoholic Fatty Liver Disease by Lysozyme Nanoparticles Delivery of Resveratrol
    Li, Xing
    Liu, Lanjun
    Hou, Guohua
    Zhang, Jipeng
    Xiao, Jie
    Li, Yuan
    Journal of Chinese Institute of Food Science and Technology, 2024, 24 (06) : 117 - 127
  • [5] Chrysin ameliorates nonalcoholic fatty liver disease in rats
    Sarayu A. Pai
    Renuka P. Munshi
    Falguni H. Panchal
    Ila-Shruti Gaur
    Archana R. Juvekar
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, 392 : 1617 - 1628
  • [6] Chrysin ameliorates nonalcoholic fatty liver disease in rats
    Pai, Sarayu A.
    Munshi, Renuka P.
    Panchal, Falguni H.
    Gaur, Ila-Shruti
    Juvekar, Archana R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 (12) : 1617 - 1628
  • [7] Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
    Hyogo, Hideyuki
    Chayama, Kazuaki
    Yamagishi, Sho-ichi
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (14) : 2403 - 2411
  • [8] Catalase and nonalcoholic fatty liver disease
    Shin, Su-Kyung
    Cho, Hyun-Woo
    Song, Seung-Eun
    Song, Dae-Kyu
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2018, 470 (12): : 1721 - 1737
  • [9] Nonalcoholic fatty liver disease - A multisystem disease?
    Mikolasevic, Ivana
    Milic, Sandra
    Wensveen, Tamara Turk
    Grgic, Ivana
    Jakopcic, Ivan
    Stimac, Davor
    Wensveen, Felix
    Orlic, Lidija
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (43) : 9488 - 9505
  • [10] Pharmacotherapy for Nonalcoholic Fatty Liver Disease
    Gawrieh, Samer
    Chalasani, Naga
    SEMINARS IN LIVER DISEASE, 2015, 35 (03) : 338 - 348
12345